NO162617C - Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater.Info
- Publication number
- NO162617C NO162617C NO851550A NO851550A NO162617C NO 162617 C NO162617 C NO 162617C NO 851550 A NO851550 A NO 851550A NO 851550 A NO851550 A NO 851550A NO 162617 C NO162617 C NO 162617C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogy procedure
- active tricyclic
- imidazold
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH196684 | 1984-04-19 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO851550L NO851550L (no) | 1985-10-21 |
| NO162617B NO162617B (no) | 1989-10-16 |
| NO162617C true NO162617C (no) | 1990-01-24 |
Family
ID=4222776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO851550A NO162617C (no) | 1984-04-19 | 1985-04-18 | Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater. |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US4634710A (pt) |
| EP (1) | EP0163842A1 (pt) |
| JP (1) | JPS60233070A (pt) |
| KR (1) | KR850007256A (pt) |
| AU (1) | AU589555B2 (pt) |
| CS (2) | CS250249B2 (pt) |
| DD (1) | DD232277A5 (pt) |
| DK (1) | DK148585A (pt) |
| ES (4) | ES8607963A1 (pt) |
| FI (1) | FI851431L (pt) |
| GR (1) | GR850949B (pt) |
| HU (1) | HU193362B (pt) |
| IL (1) | IL74880A (pt) |
| MC (1) | MC1650A1 (pt) |
| NO (1) | NO162617C (pt) |
| NZ (1) | NZ211773A (pt) |
| PH (1) | PH21046A (pt) |
| PT (1) | PT80315B (pt) |
| SU (2) | SU1362402A3 (pt) |
| ZA (1) | ZA852765B (pt) |
| ZW (1) | ZW4585A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK337086A (da) * | 1985-08-12 | 1987-02-13 | Hoffmann La Roche | Benzimidazolderivater |
| US5433959A (en) * | 1986-02-13 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
| US6749864B2 (en) * | 1986-02-13 | 2004-06-15 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
| SE9002043D0 (sv) * | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
| US6852739B1 (en) * | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| US7211590B2 (en) * | 2002-08-01 | 2007-05-01 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
| RU2487126C1 (ru) * | 2011-11-28 | 2013-07-10 | Открытое акционерное общество "Федеральный научно-производственный центр "Алтай" | Способ получения 1,4-диоксан-2,3-диола |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1805548A1 (de) * | 1968-10-26 | 1970-10-08 | Agfa Gevaert Ag | Benzimidazol-Derivate und ihre photographische Verwendung |
| IN148930B (pt) * | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| CH644116A5 (de) * | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
| US4472409A (en) * | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
| SE8300736D0 (sv) * | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
| HU193408B (en) * | 1983-05-03 | 1987-10-28 | Byk Gulden Lomberg Chem Fqb | Process for production of new tree-cycle compounds |
| IL71664A (en) * | 1983-05-03 | 1987-11-30 | Byk Gulden Lomberg Chem Fab | Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same |
| IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1985
- 1985-03-15 ZW ZW45/85A patent/ZW4585A1/xx unknown
- 1985-04-01 DK DK148585A patent/DK148585A/da not_active IP Right Cessation
- 1985-04-03 EP EP85104041A patent/EP0163842A1/de not_active Withdrawn
- 1985-04-08 US US06/720,775 patent/US4634710A/en not_active Expired - Fee Related
- 1985-04-10 FI FI851431A patent/FI851431L/fi not_active Application Discontinuation
- 1985-04-11 IL IL74880A patent/IL74880A/xx unknown
- 1985-04-12 NZ NZ211773A patent/NZ211773A/xx unknown
- 1985-04-12 ZA ZA852765A patent/ZA852765B/xx unknown
- 1985-04-15 AU AU41228/85A patent/AU589555B2/en not_active Expired - Fee Related
- 1985-04-15 PH PH32137A patent/PH21046A/en unknown
- 1985-04-16 CS CS856644A patent/CS250249B2/cs unknown
- 1985-04-16 CS CS852800A patent/CS250248B2/cs unknown
- 1985-04-17 MC MC851762A patent/MC1650A1/xx unknown
- 1985-04-17 JP JP60080423A patent/JPS60233070A/ja active Pending
- 1985-04-17 KR KR1019850002583A patent/KR850007256A/ko not_active Application Discontinuation
- 1985-04-17 HU HU851421A patent/HU193362B/hu not_active IP Right Cessation
- 1985-04-18 PT PT80315A patent/PT80315B/pt not_active IP Right Cessation
- 1985-04-18 ES ES542370A patent/ES8607963A1/es not_active Expired
- 1985-04-18 SU SU853884504A patent/SU1362402A3/ru active
- 1985-04-18 DD DD85275310A patent/DD232277A5/de not_active IP Right Cessation
- 1985-04-18 GR GR850949A patent/GR850949B/el unknown
- 1985-04-18 NO NO851550A patent/NO162617C/no unknown
-
1986
- 1986-01-31 ES ES551472A patent/ES8706124A1/es not_active Expired
- 1986-01-31 ES ES551471A patent/ES8706128A1/es not_active Expired
- 1986-01-31 ES ES551473A patent/ES8706129A1/es not_active Expired
- 1986-02-25 SU SU864025045A patent/SU1396965A3/ru active
-
1990
- 1990-01-05 US US07/463,879 patent/US4981861A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
| NO853046L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO162514C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater. | |
| NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
| NO167142C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO871266D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO165239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater. | |
| NO165192C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater. | |
| NO893616D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser. | |
| NO874032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO884174D0 (no) | Framgangsmaate for fremstilling av terapeutisk aktive tricykliske amidinoderivater. | |
| NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO161562C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater. | |
| NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO158941C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
| NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
| NO160511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater. | |
| NO830900L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. | |
| NO168478C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater. | |
| NO865012D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater. |